Trial intelligence / Profile preview

Oxytocin vs Tranexamic Acid in Abdominal Myomectomy

NCT03892668Phase 4Completed

Sponsor
Cairo University
Start
Apr 2019
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tranexamic acid in uterine leiomyoma (3 arms), sponsored by Cairo University. Primary endpoint: Intraoperative Blood loss. Started Apr 2019; status: completed.

02

Drugs

tranexamic acid
03

Conditions

uterine leiomyoma

Beyond the preview

Go deeper on NCT03892668.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03892668.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call